Durvalumab and multiple sclerosis: a causal link or simple unmasking?

MLA

Caputo, Francesca, et al. “Durvalumab and Multiple Sclerosis: A Causal Link or Simple Unmasking?” European Journal of Clinical Pharmacology, vol. 76, no. 12, Dec. 2020, pp. 1773–74. EBSCOhost, https://doi.org/10.1007/s00228-020-02959-0.

APA

Caputo, F., Manni, A., Iaffaldano, P., Trojano, M., & Paolicelli, D. (2020). Durvalumab and multiple sclerosis: a causal link or simple unmasking? European Journal of Clinical Pharmacology, 76(12), 1773–1774. https://doi.org/10.1007/s00228-020-02959-0

Chicago

Caputo, Francesca, Alessia Manni, Pietro Iaffaldano, Maria Trojano, and Damiano Paolicelli. 2020. “Durvalumab and Multiple Sclerosis: A Causal Link or Simple Unmasking?” European Journal of Clinical Pharmacology 76 (12): 1773–74. doi:10.1007/s00228-020-02959-0.